Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B cells in MS and NMO: pathogenesis and therapy
Markus Krumbholz, Edgar Meinl
Seminars in Immunopathology (2014) Vol. 36, Iss. 3, pp. 339-350
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Axon growth inhibition by RhoA/ROCK in the central nervous system
Yuki Fujita, Toshihide Yamashita
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 241
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
Joan T. Merrill, Ronald van Vollenhoven, Jill P. Buyon, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 2, pp. 332-340
Open Access | Times Cited: 205
Rituximab for the treatment of multiple sclerosis: a review
Clara Grazia Chisari, Eleonora Sgarlata, Sebastiano Arena, et al.
Journal of Neurology (2021) Vol. 269, Iss. 1, pp. 159-183
Open Access | Times Cited: 153
Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro
Yukio Takeshita, Birgit Obermeier, Anne C. Cotleur, et al.
Neurology Neuroimmunology & Neuroinflammation (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 161
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
Anne‐Katrin Pröbstel, Gabrielle Rudolf, Klaus Dornmair, et al.
Journal of Neuroinflammation (2015) Vol. 12, Iss. 1
Open Access | Times Cited: 156
A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica
Karol Estrada, Christopher W. Whelan, Fengmei Zhao, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 107
STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions
Christo Tsilifis, Alexandra F. Freeman, Andrew R. Gennery
Journal of Clinical Immunology (2021) Vol. 41, Iss. 5, pp. 864-880
Open Access | Times Cited: 100
Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases
Yang Zhou, Ying Zhang, Jinming Han, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 83
Serious safety events in rituximab‐treated multiple sclerosis and related disorders
Brandi Vollmer, Asya I. Wallach, John R. Corboy, et al.
Annals of Clinical and Translational Neurology (2020) Vol. 7, Iss. 9, pp. 1477-1487
Open Access | Times Cited: 82
Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production
Elizabeth Cotzomi, Panos Stathopoulos, Casey S. Lee, et al.
Brain (2019) Vol. 142, Iss. 6, pp. 1598-1615
Open Access | Times Cited: 81
Ravulizumab and other complement inhibitors for the treatment of autoimmune disorders
Gabriel de Deus Vieira, Vinícius Boldrini, Simone Mader, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106311-106311
Closed Access | Times Cited: 1
Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
Hélène Zéphir, Raphaël Bernard‐Valnet, Christine Lebrun‐Frénay, et al.
Journal of Neurology (2015) Vol. 262, Iss. 10, pp. 2329-2335
Closed Access | Times Cited: 90
Follicular Helper CD4+T Cells in Human Neuroautoimmune Diseases and Their Animal Models
Xueli Fan, Chenhong Lin, Jinming Han, et al.
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 88
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
Nele Claes, Judith Fraussen, Piet Stinissen, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 85
Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy
Ana Beatriz DePaula-Silva, Tyler J. Hanak, Jane E. Libbey, et al.
Journal of Neuroimmunology (2017) Vol. 308, pp. 30-42
Open Access | Times Cited: 72
Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity
Hong Qiu, Haijing Wu, Vera Chan, et al.
Autoimmunity (2017) Vol. 50, Iss. 2, pp. 71-81
Closed Access | Times Cited: 62
Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
Kazushiro Takata, Panos Stathopoulos, Michelangelo Cao, et al.
JCI Insight (2019) Vol. 4, Iss. 12
Open Access | Times Cited: 57
Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis
Xueli Fan, Tao Jin, Songchen Zhao, et al.
PLoS ONE (2015) Vol. 10, Iss. 7, pp. e0134523-e0134523
Open Access | Times Cited: 50
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
Omid Mirmosayyeb, Masoud Etemadifar, Mehri Salari, et al.
Journal of Research in Medical Sciences (2017) Vol. 22, Iss. 1, pp. 18-18
Open Access | Times Cited: 50
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience
Emanuele D’Amico, Aurora Zanghì, Clara Grazia Chisari, et al.
Multiple Sclerosis and Related Disorders (2018) Vol. 27, pp. 324-326
Closed Access | Times Cited: 48
Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis
Yoshio Bandô, Taichi Nomura, Hiroki Bochimoto, et al.
Neurochemistry International (2015) Vol. 81, pp. 16-27
Closed Access | Times Cited: 47
CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics
Chen Ding, Sara Ireland, Gina Remington, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 11, pp. 4257-4265
Open Access | Times Cited: 46
T Follicular Helper-Like Cells Are Involved in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Jun Guo, Cong Zhao, Fang Wu, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 44
Anti-CD20 monoclonal antibodies in multiple sclerosis
Irene Moreno‐Torres, Antonio García‐Merino
Expert Review of Neurotherapeutics (2016) Vol. 17, Iss. 4, pp. 359-371
Closed Access | Times Cited: 43
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis
Orhan Aktaş, Philipp Albrecht, Hans‐Peter Hartung
Current Opinion in Neurology (2016) Vol. 29, Iss. 3, pp. 199-204
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top